Physician profile
Laura A Coyle
NPI 1881864213
$34,326.25
in general payments reported to CMS, 2019-2025
5 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,211 · 2022: $2,721 · 2023: $7,441 · 2024: $9,475 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $7,255 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,645 · Food and Beverage: $4,757 · Entertainment: $14.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,723.25 |
| Travel and Lodging | $7,255.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,645.00 |
| Food and Beverage | $4,757.15 |
| Entertainment | $14.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,673.08 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Thoratec Heartmate II, Lvas Implant Kit |
| Medtronic, INC. | $13,502.01 | 2021-2025 | Hvad Pump Implant Kit |
| Abiomed | $113.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.73 | 2021 | |
| Argentum Medical | $14.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.